HYDROQUINONE 2% + TRETINOIN 0.025% + MOMETASONE FUROATE 0.1%
| Composition | HYDROQUINONE 2% + TRETINOIN 0.025% + MOMETASONE FUROATE 0.1% |
|---|---|
| Packing | 15 gm |
| MRP | UPCOMING |
| Dosage Form | Topical |
GLOWZIA-HC CREAM is a dermatologist-prescribed combination topical cream containing Hydroquinone 2%, Tretinoin 0.025%, and Mometasone Furoate 0.1%. This triple-action formulation is designed to address stubborn skin pigmentation by targeting the appearance of dark spots, uneven skin tone, and melasma with a multi-pronged approach.
By combining a melanin-inhibiting agent, a vitamin A derivative that promotes healthy skin cell turnover, and a mild corticosteroid to manage associated inflammation, GLOWZIA-HC CREAM offers a comprehensive solution for hyperpigmentation commonly seen in Indian skin tones.
This medicine is commonly used for:
Indicated for the short-term topical treatment of melasma, post-inflammatory hyperpigmentation, and solar lentigines. Mometasone furoate provides anti-inflammatory control to reduce erythema associated with active depigmentation therapy. The combination is prescribed under dermatological supervision given the potency of its components.
Hydroquinone reduces melanin production — the pigment that causes dark spots — in the skin. Tretinoin speeds up the natural shedding of darkened skin cells, helping lighter, newer skin come through faster. Mometasone furoate calms any irritation or redness that might occur during the process, making the treatment more comfortable.
Hydroquinone inhibits tyrosinase, the rate-limiting enzyme in melanin biosynthesis, reducing melanin production in melanocytes. Tretinoin (all-trans retinoic acid) binds to nuclear retinoic acid receptors (RARs), accelerating keratinocyte turnover and dispersion of melanin granules while promoting dermal collagen synthesis. Mometasone furoate, a medium-potency synthetic glucocorticoid, binds cytoplasmic glucocorticoid receptors and reduces pro-inflammatory cytokines, thereby mitigating the irritation often associated with hydroquinone and retinoid use.
Tretinoin was originally studied as an acne treatment in the 1960s, but researchers soon discovered it also significantly fades pigmentation and reduces fine lines — making it one of the most studied and clinically validated ingredients in dermatology.
Apply GLOWZIA-HC CREAM as directed by your dermatologist, typically to the affected area once daily in the evening. Always follow your doctor's prescribed duration and frequency — do not apply more than recommended. Sun protection during the day is essential while using this cream.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
Some users may experience mild redness, dryness, peeling, or a mild burning sensation at the application site, especially during the first few weeks. Prolonged use of corticosteroid-containing creams may cause skin thinning if used beyond the recommended period. Tell your doctor if any side effect is severe or persistent.
Skin-lightening creams permanently remove pigmentation in a few days.
Depigmentation treatments like GLOWZIA-HC CREAM work gradually over weeks to months. Consistent use under dermatological supervision and daily sun protection are key for lasting results.
You can use this cream indefinitely to maintain fair skin.
GLOWZIA-HC CREAM contains a corticosteroid and should only be used for the duration prescribed by your dermatologist. Prolonged unsupervised use can cause unwanted side effects such as skin thinning.
KETOCONAZOLE 20 MG + IODOCHLORHYDROXYQUINOLINE 10 MG + TOLNAFTATE 10 MG + NEOMYCIN 1 MG + CLOBETASOL PROPIONATE 0.05 MG + DEXPANTHENOL 0.5 MG
Ofloxacin 0.75% + Ornidazole 2.0% + Itraconazole 1% + Clobetasol 0.05%
Luliconazole Cream 1.0% w/w
Diclofenac Diethylamine 1.16% Eq. to Diclofenac Sodium 1% + Methyl Salicylate 10% + Oleum Lini 3% + Menthol 5% + Benzyl Alcohol 1% w/v